SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

US FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded Weight‑loss Drugs

The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ⁠claims about compounded versions of popular GLP-1...

US FDA Warns Novo Again About Misleading Drug Advertising

The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, ⁠Ozempic, saying the commercial makes false and...

Scenarios Show How to Plan for Osteoporosis Drug Sequences

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

Does HRT Lower Osteoporosis Risk?

New research suggests early initiation of hormone replacement therapy could protect bone health.

HRT Patches Superior to Oral Meds for FHA-Related Bone Loss

With the risk for bone fracture high in patients with amenorrhea caused by anorexia or excessive exercise, studies show transdermal HRT provides more favorable bone benefits than oral HRT.

Aardvark Pauses Late-stage Trial Testing Rare Disease Treatment

Aardvark Therapeutics is voluntarily pausing its late-stage trial testing its experimental treatment for a ⁠type of rare genetic disease after it found heart-related side...

Todays Updates

Should Biology Replace Organ Labels in Cancer Treatment?

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Todays Updates

Should Biology Replace Organ Labels in Cancer Treatment?

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Latest News

The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ⁠claims about compounded versions of popular GLP-1...

The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, ⁠Ozempic, saying the commercial makes false and...

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

New research suggests early initiation of hormone replacement therapy could protect bone health.

With the risk for bone fracture high in patients with amenorrhea caused by anorexia or excessive exercise, studies show transdermal HRT provides more favorable bone benefits than oral HRT.

Aardvark Therapeutics is voluntarily pausing its late-stage trial testing its experimental treatment for a ⁠type of rare genetic disease after it found heart-related side...

News All Time

What Boosts Adherence to GLP-1s?

GLP-1s sometimes cause unpleasant side effects that can lead to nonadherence and discontinuation, but some patients stay the course anyway. What factors motivate them not to give up?

Big Breakfast Alters Appetite, Gut Health

Breakfast meals higher in protein promote feelings of satiety, and those higher in fiber boost beneficial gut microbiota — both lead to weight loss and metabolic benefits.

Diabetes and Mental Health Care Gaps Exposed

A national investigation has found that gaps between diabetes and mental health services are exposing insulin-treated adults to avoidable harm and death.

US FDA Approves Eton's Liquid Therapy for Rare Water-balance Disorder

The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a ⁠rare hormonal disorder, offering a more precise...

Nearly a Third of US Youth Have Prediabetes or Diabetes

Nearly 1 in 3 US adolescents have prediabetes or type 2 diabetes, with abdominal adiposity being the strongest independent predictor, analysis of national survey data from 2021 to 2023 shows.

Gut Flora May Be Altered by Oral Semaglutide Additive

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT Excels at Classifying Ultraprocessed Foods

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

GPs ‘Reeling’ Over New Contract in England

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

GLP-1 Drugs May Raise Fracture Risk in Older Adults With T2D

GLP-1 therapy is linked to an increased risk for fragility fractures among older adults with type 2 diabetes.

Healthy Lifestyle Lowers Cancer Survivor Mortality Risk

A large German cohort study finds that adherence to key lifestyle recommendations is associated with up to 32% lower mortality rate among long-term cancer survivors.

Hormone Therapy Myths Hinder Bone Health in Menopause

Experts warn that misinformation about menopausal hormone therapy may be increasing fracture risk in women.

Novo Nordisk, United Laboratories 'triple G' Drug Trial Shows 19.7% Weight Loss

Novo Nordisk and United Laboratories International said on Tuesday a Chinese mid-stage trial of their jointly developed "triple G" UBT251 obesity ⁠drug candidate resulted in...

Can Remote Monitoring for Diabetes Reduce Hospitalizations?

Statistics routinely show remote monitoring works, but it takes a collaborative effort.

CT-Based Approach Can Guide Pancreatic Stone Treatment

In patients with chronic pancreatitis, electrohydraulic lithotripsy performed via peroral pancreatoscopy can remove pancreatic duct stones, except for large or dense stones.

Most Americans With Obesity Perceive Just Having Overweight

Experiences of stigma and bias vary across ethnic and racial groups.

Recommended News For You

Microplastics can cause malignant changes in lung cells

Study shows virtual reality headsets may help ease cancer pain

New imaging solution could help improve survival for patients with recurring prostate cancer

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Pancreatic cancer RNA vaccine shows durable T cell immunity

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Recommended Articles For You

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Angina Haemorrhagica Bullosa: What You Need to Know 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

2.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

3.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

4.

In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.

5.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

1.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

2.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

3.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

4.

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment

5.

Angina Haemorrhagica Bullosa: What You Need to Know

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

4.

Navigating the Complexities of Ph Negative ALL - Part V

5.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot